View Clinical Trial (Medical Research Study)
A Pediatric Longitudinal Evaluation to Assess the Long-Term Safety of Protopic for the Treatment of Atopic Dermatitis - NCT00475605-14075(Clinical Trial 107945)
ClinicalConnection.com has recently undergone an update and this page may no longer be up-to-date. Please Search For Clinical Trials to view the most current clinical trials listings.
| City: |
|
Hamburg |
|
State:
|
|
NY |
| Zip Code: |
|
14075 |
| Conditions: |
|
Atopic Dermatitis |
| Purpose: |
|
This is an observational study to assess the long-term safety of Protopic® Ointment for the
treatment of atopic dermatitis. Patients whose ages are/were < 16 years at the time of
first tacrolimus ointment exposure are eligible to participate. No drug is distributed
during this observational trial.
|
| Study summary: |
|
Data will be collected at enrollment and every 6 months thereafter either by interview,
Internet, or physician office visit. Each subject will be followed for 10 years in this
study. |
| Criteria: |
|
Inclusion Criteria:
- Subjects who first used Protopic® 0.03% or 0.1% before they were sixteen years of age
and were treated for at least 6 weeks for the treatment of Atopic dermatitis may
enroll into the study. |
|
|
|
| Study is available at: |
|
Hamburg, NY 14075
United States
Primary Contact:
APPLES Study Line
Email: clintrials.info@us.astellas.com
Phone: (877) 277-7530 |
|
|
If you are interested in this clinical trial please use the contact information above. If you would like to get additional information about this clinical trial please visit ClinicalTrials.gov.
|
| Trials Alerts: |
|
If you would like to be
notified of new clinical trials as they become available please
register for a free account.
|
|
| Data Source: |
|
ClinicalTrials.gov |
| Date Processed: |
|
March 22, 2011 |
Modifications to
this listing: |
|
Only selected fields are shown, please use the link
above to view all information about this clinical trial. |
|
|
|
|
|
|
|
|